MetaCap

Phio Pharmaceuticals Corp. Company Profile

NASDAQ: PHIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.656-0.059 (-8.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Phio Pharmaceuticals at a glance

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in King of Prussia, PA. Phio Pharmaceuticals is led by Mr. Robert J. Bitterman and employs about 6 people. At a market capitalization of $7.8 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001533040, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Phio Pharmaceuticals do?

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Business description based on the company's public filings.

Company information

Legal name
Phio Pharmaceuticals Corp.
Ticker
NASDAQ: PHIO
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Robert J. Bitterman
Employees
6
Headquarters
411 Swedeland Road, King of Prussia, PA, United States
Phone
610 947 0251
SEC CIK
0001533040
Latest annual report
10-K · Mar 5, 2026

Companies similar to Phio Pharmaceuticals

PHIO peer companies
CompanyPrice% ChgMarket capCompare
CLRBCellectar Biosciences Inc.0.797-11.50%$8.00Mvs PHIO
DAREDare Bioscience Inc.0.4074-9.87%$8.01Mvs PHIO
VTGNVistagen Therapeutics Inc.0.1636-12.33%$7.56Mvs PHIO
PTNPalatin Technologies Inc.4.58-7.10%$8.16Mvs PHIO
MBRXMoleculin Biotech Inc.7.74-2.40%$8.22Mvs PHIO
RKTORocket One Inc.0.297+5.24%$7.39Mvs PHIO
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares1.29-9.15%$8.29Mvs PHIO
IMRNImmuron Limited ADR0.8998+5.80%$7.26Mvs PHIO

Related